Search Results - Matthew Sims

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Self-Concern Across Scales: A Biologically Inspired Direction for Embodied Artificial Intelligence by Matthew Sims

    Published in Frontiers in Neurorobotics (2022-04-01)
    Get full text
    Article


  2. 2

    Vestibular neuritis caused by severe acute respiratory syndrome coronavirus 2 infection diagnosed by serology: Case report by Alexandra Halalau, Madalina Halalau, Christopher Carpenter, Amr E Abbas, Matthew Sims

    Published in SAGE Open Medical Case Reports (2021-05-01)
    Get full text
    Article


  3. 3

    New diagnostic methods for Escherichia marmotae and the first report of its identification in clinical isolates in North America by Pelumi M. Oladipo, Robert J. Tibbetts, Audun Sivertsen, Justin M. Barger, Torbjørn S. Bruvold, Alemu Fite, Matthew Sims, Marcus Zervos, Ali Jomaa, Jeffrey L. Ram, Jeffrey L. Ram

    Published in Frontiers in Microbiology (2025-09-01)
    Get full text
    Article


  4. 4

    Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI by Matthew Sims, Charles Berenson, Stuart Cohen, Elaine Wang, Elizabeth Hohmann, Richard Nathan, Alberto Odio, Paul Cook, Kelly Brady, David Lombardi, Asli Memisoglu, Ananya De, Brooke Hasson, Bret Lashner, Louis Korman, Doria Grimard, Juan Carlos Moises Gutierrez, Barbara McGovern, Lisa Von Moltke

    Get full text
    Article


  5. 5

    Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection by Matthew Sims, Michael Silverman, Thomas Louie, Elaine Wang, Colleen Kraft, Mayur Ramesh, Tatiana Bogdanovich, Kelly Brady, David Lombardi, Asli Memisoglu, Ananya De, Brooke Hasson, Christine Lee, Paul Feuerstadt, Darrell Pardi, Colleen Kelly, Peter Daley, Godson Oguchi, Barbara McGovern, Lisa Von Moltke

    Get full text
    Article


  6. 6

    SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI) by Sahil Khanna, Matthew Sims, Thomas J. Louie, Monika Fischer, Kerry LaPlante, Jessica Allegretti, Brooke R. Hasson, Allyson T. Fonte, Christopher McChalicher, David S. Ege, Jessica A. Bryant, Timothy J. Straub, Christopher B. Ford, Matthew R. Henn, Elaine E. L. Wang, Lisa von Moltke, Mark H. Wilcox

    Published in Antibiotics (2022-09-01)
    Get full text
    Article


  7. 7

    Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators

    Published in Infectious Diseases and Therapy (2024-06-01)
    Get full text
    Article


  8. 8

    Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators

    Published in Infectious Diseases and Therapy (2024-08-01)
    Get full text
    Article


Search Tools: